Drug safety notice: Mepacrine hydrochloride

July 6, 2020

BCM Specials Limited has informed us that a number of foreign body particulates including glass and rubber have been found in one of the containers of the active pharmaceutical ingredient (API) used in the manufacture of mepacrine hydrochloride 100mg tablets.

We advise colleagues to stop supplying the above products immediately and remove from the shelves within your store. Quarantine all remaining stock and return it to your supplier using your supplier’s approved process.

Note: The Trust does not hold any of the affected batch.

For further details please see Mepacrine hydrochloride 100mg tablet recall information sheet.

For more information please contact the pharmacy department (City ext. 5263, Sandwell ext. 3783).